Management

NNE has a two-tier structure: the Board of Directors and NNE Management. The Board of Directors supervise the performance, management and organisation of our company and are elected every year at the Annual General Meeting. They consist of two representatives from our parent company, Novo Nordisk, plus two external members and two employee representatives. NNE Management are responsible for our daily operations and consist of executive management and seven country managers.

NNE Management

Jesper Kløve

CEO and President

Jesper Kløve was appointed CEO and President of NNE on 1 September 2015. He comes from Novo Nordisk, where he served as Senior Vice President of Device R&D and was responsible for research and development of the entire medical device portfolio since 2009. He also held various management positions within Novo Nordisk since joining the company in 2003.

René Holmen Pedersen

CFO and Corporate Vice President

René Holmen Pedersen was appointed CFO of NNE on 1 May 2016. Since 2014, René was Director of Business Support at the DFP Site, Tianjin in China. Prior to that, René held various positions at Novo Nordisk since joining in 1998 as a Corporate Business Analyst.

Alex Severin

Corporate Vice President, Global Best Practice

Alex Severin was appointed Corporate Vice President of Global Best Practice in 2015. Prior to his appointment, he held positions at NNE since 2002 including Department Manager, Vice President of Automation and IT and General Manager of Global Consulting.

Ole Regnar Hansen

Corporate Vice President and Chief Project Officer

Ole Regnar Hansen was appointed Corporate Vice President and Chief Project Officer in 2015. Prior to this, he served as Corporate Vice President for Project Governance since 2011. He joined NNE in 1999 and has since held several managerial positions in both project and line management. He has been with the Novo Nordisk Group for 29 years.

Michael Topp

Project Director and General Manager, US

Michael Topp is interim President and General Manager in 2018 for NNE US. Prior to his appointment, he held positions as Project Director for projects in Asia, Europe, and Americas. He has been with the Novo Group since 2004.

Kenneth Borch Larsen

Corporate Vice President and General Manager, China

Kenneth Borch Larsen was appointed Corporate Vice President and General Manager of China in January 2016. Prior to his appointment, he served as Project Director within NNE in Denmark. Kenneth Borch Larsen joined NNE in 2005 and has previously worked for NNE in China from 2006-2014.

Sameer Taneja

Corporate Vice President and General Manager, India

Sameer Taneja was appointed Corporate Vice President and General Manager of India in 2015. He has more than 20 years of experience in engineering. Before joining NNE, he served as a department manager for a company specialising in HVAC project execution.

Olivier Cozzatti

Corporate Vice President and General Manager, France and Belgium

Olivier Cozzatti was appointed Corporate Vice President and General Manager of Belgium and France in 2016, previously serving as Operational Director of France since 2014. Olivier Cozzatti has 15 years of pharmaceutical industry experience and worked as Export Sales Manager for PCM (food business unit), before joining NNE in 2009 as Sales Director.

Stefan Berg

Corporate Vice President and General Manager, Switzerland

Stefan Berg was appointed Corporate Vice President and General Manager of Switzerland in 2015, previously serving as Regional Manager of Central Europe and Corporate Vice President since 2011. Before joining NNE in 2004, Stefan Berg held various project and line management positions within the pharmaceutical engineering business in Switzerland and Germany.

 

Eric Pierre Riehl

Corporate Vice President and General Manager, Germany

Eric Pierre Riehl was appointed General Manager of Germany in 2016, previously serving as General Manager of France and Belgium since 2015 and France since 2012. He has 16 years of pharmaceutical industry experience. He has served as a Project Director for NNE since 2011.

Karsten Munk Knudsen

Chairman of the NNE Board since 2017

Karsten Munk Knudsen, CFO and EVP for Finance, Investor Relations & Procurement, Novo Nordisk A/S. Karsten joined Novo Nordisk in 2003 and has occupied several positions over the years within finance, both in Denmark and in the US. 1999-2003, Karsten headed up Finance in NNIT.

Birgit W. Nørgaard

Vice Chairman of the NNE Board since 2014 and member of the Board since 2011

Birgit Nørgaard has worked as a full-time Board member since 2010. Prior to this, she was CEO of Grontmij | Carl Bro A/S and COO of Grontmij NV, CEO of the Carl Bro Group 2003 – 2006 and CFO 2001 – 2003. Previously, Birgit Nørgaard held executive positions at TDC and Danisco.

Lis Thodberg

Employee-elected member of the NNE Board since 2018

Lis Thodberg (MSc Biology) is Director for the Health, Safety & Environment department at NNE since 2013. Furthermore she is responsible for driving corporate sustainability management in NNE. 

Michael Hallgren

Member of the NNE board since 2018

Michael Hallgren is Senior Vice President of Diabetes Active Pharmaceutical Ingredients at Novo Nordisk A/S, which he joined in 1994. In addition to his NNE Board role, Michael is Chairman of Kalundborg Symbiosis and member of the Board of Directors at Novo Nordisk Pharmatech A/S.

David Victor Tackie

Employee-elected member of the NNE Board since 2017

David Victor Tackie has been the Manager for the Electrical and Instrumentation department at NNE in Denmark since 2015. He has held a number of management and project management positions both globally and locally.

Corporate governance

 

NNE A/S is 100% owned by Novo Nordisk A/S and is included in the Consolidated Financial Statements of Novo Nordisk A/S.